l carnitine tmao nature medicine 2013 koeth Dietary allicin reduces transformation of L-carnitine to through impact on gut microbiota γ–Butyrobetaine is a pro-atherogenic intermediate
Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC A Multi omic Association Study of Trimethylamine N Oxide ScienceDirect Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target PMC Intestinal microbiota metabolism of L carnitine, a nutrient in red meat, promotes atherosclerosis PMC
Pay in 4 interest-free payments of $5.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



